2 completed. 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Anti-D Antibodies: new trials by email Literature Review of Anti-D Antibodies trials Research Report on Anti-D Antibodies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RHD Genotype Matched Red Cells for Anti-D D+ RH genotype matched red cell units for transfusion - Sickle Cell Disease, Anti-D Antibodies | Early Phase 1 | Completed | Children's Hospital of Philadelphia | 5 | 2020-07-08 | 2025-05-02 |
| The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use Zagreb2-1-1, Essen - Rabies Vaccine Allergy, Vaccination Adverse Event | Phase 4 | Completed | Beijing Center for Disease Control and Prevention | 10500 | 2012-07-01 | 2016-01-20 |
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1)
Beijing Center for Disease Control and Prevention (1) · Children's Hospital of Philadelphia (1)
China (1) · United States (1)
Nianmin Shi (1) · Stella Chou, MD (1)
PMID 28121231, PMID 39172743, PMID 39358206, PMID 42376265
R01HL147879 (1)